Tower Research Capital (TRC)’s PhenomeX Inc. Common Stock CELL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-885
| Closed | -$883 | – | 6390 |
|
|
2023
Q3 | $883 | Sell |
885
-17,894
| -95% | -$13.7K | ﹤0.01% | 5452 |
|
|
2023
Q2 | $9.2K | Buy |
18,779
+5,262
| +39% | +$4.3K | ﹤0.01% | 4321 |
|
|
2023
Q1 | $16K | Buy |
13,517
+6,053
| +81% | +$11.1K | ﹤0.01% | 3753 |
|
|
2022
Q4 | $20K | Sell |
7,464
-16,154
| -68% | -$42.6K | ﹤0.01% | 3158 |
|
|
2022
Q3 | $67K | Buy |
23,618
+11,261
| +91% | +$47.9K | ﹤0.01% | 2904 |
|
|
2022
Q2 | $61K | Buy |
12,357
+11,334
| +1,108% | +$59.4K | ﹤0.01% | 2709 |
|
|
2022
Q1 | $7K | Sell |
1,023
-26
| -2% | -$215 | ﹤0.01% | 4809 |
|
|
2021
Q4 | $19K | Sell |
1,049
-5,670
| -84% | -$122K | ﹤0.01% | 3758 |
|
|
2021
Q3 | $131K | Sell |
6,719
-267
| -4% | -$10.2K | ﹤0.01% | 2172 |
|
|
2021
Q2 | $313K | Sell |
6,986
-10,104
| -59% | -$468K | 0.01% | 1573 |
|
|
2021
Q1 | $859K | Buy |
17,090
+12,198
| +249% | +$832K | 0.01% | 855 |
|
|
2020
Q4 | $437K | Buy |
4,892
+3,959
| +424% | +$333K | 0.01% | 1093 |
|
|
2020
Q3 | $71K | Buy |
+933
| New | +$59.2K | ﹤0.01% | 3384 |
|
Tower Research Capital (TRC)'s CELL Position: Q4 2023 in Review
Tower Research Capital (TRC) sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 885 shares — an estimated $883 sold.
Tower Research Capital (TRC) first reported a position in CELL in Q3 2020 and held it in 13 quarters. The position peaked at $859K in Q1 2021. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.
- Tower Research Capital (TRC) reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Tower Research Capital (TRC) sold 885 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $883.
- Tower Research Capital (TRC) first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 13 quarters.
- Tower Research Capital (TRC)'s PhenomeX Inc. Common Stock position peaked at $859K in Q1 2021.
- 0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.